Instrument Inactif

Communiqués GlaxoSmithKline plc London S.E.

Actions

Produits pharmaceutiques

Cours en clôture London S.E. Autres places de cotation
- ^GBX	-

12/06	Les bourses européennes clôturent en hausse : ralentissement de l'inflation en Allemagne et contraction du PIB britannique	MT
12/06	Le traitement de GSK contre les troubles myéloïdes clonaux obtient le statut de médicament orphelin aux États-Unis et en Europe	MT

Communiqués

01/06	PrEP Wisdom: ViiV Healthcare Launches New Campaign to Support Informed HIV Prevention Choices	BU
28/05	GSK : Bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic hepatitis B	PU
26/05	GSK : to showcase long-term outcomes and pipeline expansion with latest oncology research at ASCO and EHA	PU
18/05	GSK : RSV vaccine, Arexvy, receives expanded approval in Japan for adults aged 18–59 at increased risk	PU
11/05	GSK : enters exclusive collaboration with SBP Group, a market leader in hepatology in China, to accelerate bepirovirsen at launch	PU
07/05	Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults	BU
06/05	GSK : 2026 Remuneration Policy	PU
06/05	GSK : presents latest respiratory research to advance patient care at ATS 2026	PU
30/04	GSK : Q1 2026 results transcript	PU
29/04	The Fifth International Healthcare Week set for next month	AQ
29/04	Glaxo: Q1 Earnings Snapshot	AQ
29/04	GSK : Q1 2026 results slides	PU
29/04	GSK : Q1 2026 pipeline assets and clinical trials report	PU
29/04	GSK : Q1 2026 results infographic	PU
29/04	GSK : Q1 2026 US dollar translation	PU
29/04	GSK : delivers strong Q1 performance and start to 2026	PU
28/04	GSK : Bepirovirsen accepted for priority review and granted Breakthrough Therapy Designation by the US FDA	PU
27/04	GSK : investigational liver therapy, efimosfermin, receives US FDA Breakthrough Therapy and EMA Priority Medicines (PRIME) designations for MASH	PU
12/04	GSK : presents positive data for B7-H4-targeted ADC in gynaecological cancers	PU
10/04	The Time to Talk about HIV is Now: ViiV Healthcare Launches "Still Here" PSA to Ignite Action Around HIV on National Youth HIV/AIDS Awareness Day	BU
09/04	GSK : Q1 2026 pre announcement aide memoire	PU
30/03	GSK plc - Bepirovirsen accepted for review by the European Medicines Agency as a potential first-in-class treatment for chronic hepatitis B	AQ
25/03	GSK : Articles of Association - Proposed Amendments	PU
25/03	GSK : Proxy Form 2026	PU
25/03	GSK : Notice of AGM 2026	PU